Clinical Trials Browser

Phase 4 × Lung Neoplasms × Rivaroxaban × Clear all

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism